| Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression J Luan, R Shattuck‐Brandt, H Haghnegahdar, JD Owen, R Strieter, ... Journal of leukocyte biology 62 (5), 588-597, 1997 | 245 | 1997 |
| The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma H Haghnegahdar, J Du, DZ Wang, RM Strieter, MD Burdick, LB Nanney, ... Journal of leukocyte biology 67 (1), 53-62, 2000 | 228 | 2000 |
| Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL–10−/− mice RL Shattuck-Brandt, GW Varilek, A Radhika, F Yang, MK Washington, ... Gastroenterology 118 (2), 337-345, 2000 | 223 | 2000 |
| Enhanced tumor‐forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth‐regulated cytokine β and γ proteins JD Owen, R Strieter, M Burdick, H Haghnegahdar, L Nanney, ... International journal of cancer 73 (1), 94-103, 1997 | 202 | 1997 |
| The role of COX-2 in intestinal cancer CS Williams, RL Shattuck-Brandt, RN DuBois Expert Opinion on Investigational Drugs 8 (1), 1-12, 1999 | 187 | 1999 |
| Enhanced degradation of I-κBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells RL Shattuck-Brandt, A Richmond Cancer research 57 (14), 3032-3039, 1997 | 184 | 1997 |
| Reduced COX-2 protein in colorectal cancer with defective mismatch repair WE Karnes, R Shattuck-Brandt, LJ Burgart, RN DuBois, DJ Tester, ... Cancer Research 58 (23), 5473-5477, 1998 | 175 | 1998 |
| Differential expression of matrilysin and cyclooxygenase‐2 in intestinal and colorectal neoplasms RL Shattuck‐Brandt, LW Lamps, KJ Heppner Goss, RN DuBois, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 1999 | 121 | 1999 |
| MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21 AE Vilgelm, N Saleh, R Shattuck-Brandt, K Riemenschneider, L Slesur, ... Science translational medicine 11 (505), eaav7171, 2019 | 83 | 2019 |
| Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction RA Wagenaar-Miller, G Hanley, R Shattuck-Brandt, RN DuBois, RL Bell, ... British journal of cancer 88 (9), 1445-1452, 2003 | 48 | 2003 |
| Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids A Vilgelm, K Bergdorf, M Wolf, V Bharti, R Shattuck-Brandt, A Blevins, ... Iscience, 101408, 2020 | 40 | 2020 |
| Metastatic Melanoma Patient-derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition RL Shattuck-Brandt, SC Chen, E Murray, CA Johnson, H Crandall, ... Clinical Cancer Research, 2020 | 26 | 2020 |
| Identification and characterization of an MGSA/GRO pseudogene RL Shattuck-Brandt, LD Wood, A Richmond DNA Sequence 7 (6), 379-386, 1997 | 14 | 1997 |
| The molecular basis of colorectal carcinogenesis RL Shattuck-Brandt, RN DuBois Current opinion in gastroenterology 15 (1), 3, 1999 | 13 | 1999 |
| The role of melanoma growth-stimulatory activity in melanoma tumorigenesis and angiogenesis A Richmond, H Haghnegahdar, R Shattuck-Brandt, LD Wood, CS Nirodi, ... Chemokines and Cancer, 169-189, 1999 | 1 | 1999 |
| Cyclooxygenase-2 (COX-2) expression in Barrett's esophagus HM Kandil, G Tanner, W Smalley, S Halter, A Radhika, R Shattuck-Brandt, ... GASTROENTEROLOGY 116 (4), A431-A431, 1999 | | 1999 |
| Wintrobe’s Clinical Hematology RL Shattuck-Brandt, SJ Brandt | | |
| PART I LABORATORY HEMATOLOGY SL Perkins, F Paraskevas, SNJ Sait, MR Baer, RL Shattuck-Brandt, ... | | |
